| Matthew S Horsfield, MD | |
|
3701 Kirby Dr, Suite 100, Houston, TX 77098-3900 | |
| (713) 798-7700 | |
| (713) 798-7775 |
| Full Name | Matthew S Horsfield |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 30 Years |
| Location | 3701 Kirby Dr, Houston, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013998129 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 18082 (South Carolina) | Secondary |
| 207Q00000X | Family Medicine | 12242R (Louisiana) | Secondary |
| 207Q00000X | Family Medicine | M5232 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Reliant Medical Group Inc | 5597755322 | 543 |
News Archive
15% of patients experience more pain, physical and emotional problems a year after surgery than before their operation and 24% have less vitality, according to a study of over 400 patients published online by the British Journal of Surgery.
A drug commonly used to control high blood pressure may also help prevent the onset of type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz Medical Campus and the University of Florida in Gainesville.
New WHO data finds that unsafe food kills an estimated 1.2 million people over the age of five in Southeast Asia and Africa each year, including three times more adults than previously thought, Reuters reports. "It is a picture that we have never had before," WHO Food Safety Director Jorgen Schlundt said. "We now have documentation of a significant burden outside the less than five group, that is major new information."
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, announced today results from its pilot study evaluating the cancer detection abilities of one of its lead monoclonal antibody product candidates, ICT-109. Data from this study demonstrated that ICT-109 had a statistically significant ability to discriminate between cancerous and non-cancerous samples, suggesting the potential to detect pancreatic and lung cancer in plasma and serum study sets.
Obese adults with poorly controlled Type 1 diabetes can better control their blood sugar by adding liraglutide, a Type 2 diabetes drug, to their insulin therapy, a new study finds. The results, which will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston, also found that these diabetic patients lost weight and lowered their blood pressure.
› Verified 1 days ago
| Entity Name | Reliant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720017528 PECOS PAC ID: 5597755322 Enrollment ID: O20040708000650 |
News Archive
15% of patients experience more pain, physical and emotional problems a year after surgery than before their operation and 24% have less vitality, according to a study of over 400 patients published online by the British Journal of Surgery.
A drug commonly used to control high blood pressure may also help prevent the onset of type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz Medical Campus and the University of Florida in Gainesville.
New WHO data finds that unsafe food kills an estimated 1.2 million people over the age of five in Southeast Asia and Africa each year, including three times more adults than previously thought, Reuters reports. "It is a picture that we have never had before," WHO Food Safety Director Jorgen Schlundt said. "We now have documentation of a significant burden outside the less than five group, that is major new information."
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, announced today results from its pilot study evaluating the cancer detection abilities of one of its lead monoclonal antibody product candidates, ICT-109. Data from this study demonstrated that ICT-109 had a statistically significant ability to discriminate between cancerous and non-cancerous samples, suggesting the potential to detect pancreatic and lung cancer in plasma and serum study sets.
Obese adults with poorly controlled Type 1 diabetes can better control their blood sugar by adding liraglutide, a Type 2 diabetes drug, to their insulin therapy, a new study finds. The results, which will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston, also found that these diabetic patients lost weight and lowered their blood pressure.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew S Horsfield, MD 3701 Kirby Dr, Suite 100, Houston, TX 77098-3900 Ph: (713) 798-7700 | Matthew S Horsfield, MD 3701 Kirby Dr, Suite 100, Houston, TX 77098-3900 Ph: (713) 798-7700 |
News Archive
15% of patients experience more pain, physical and emotional problems a year after surgery than before their operation and 24% have less vitality, according to a study of over 400 patients published online by the British Journal of Surgery.
A drug commonly used to control high blood pressure may also help prevent the onset of type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz Medical Campus and the University of Florida in Gainesville.
New WHO data finds that unsafe food kills an estimated 1.2 million people over the age of five in Southeast Asia and Africa each year, including three times more adults than previously thought, Reuters reports. "It is a picture that we have never had before," WHO Food Safety Director Jorgen Schlundt said. "We now have documentation of a significant burden outside the less than five group, that is major new information."
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, announced today results from its pilot study evaluating the cancer detection abilities of one of its lead monoclonal antibody product candidates, ICT-109. Data from this study demonstrated that ICT-109 had a statistically significant ability to discriminate between cancerous and non-cancerous samples, suggesting the potential to detect pancreatic and lung cancer in plasma and serum study sets.
Obese adults with poorly controlled Type 1 diabetes can better control their blood sugar by adding liraglutide, a Type 2 diabetes drug, to their insulin therapy, a new study finds. The results, which will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston, also found that these diabetic patients lost weight and lowered their blood pressure.
› Verified 1 days ago
Dr. Jeanette Ferrer, D.O Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6565 Fannin St., Main 577, Houston, TX 77030 Phone: 713-441-0428 | |
Dr. Bhavik Kumar, MD, MPH Family Medicine Medicare: Medicare Enrolled Practice Location: 4600 Gulf Fwy, Houston, TX 77023 Phone: 713-522-3976 Fax: 404-494-7435 | |
Nneka Okafor, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3701 Kirby Dr Ste 600, Houston, TX 77098 Phone: 713-798-8072 | |
Dr. Rolando R Maldonado I, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 548 Waugh Dr, Houston, TX 77019 Phone: 713-933-0501 | |
Scott H Hung, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10950 Resource Pkwy, Suite A, Houston, TX 77089 Phone: 281-484-5587 Fax: 281-506-1013 | |
Michael E. Buxbaum, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6699 Chimney Rock Rd Ste 201, Houston, TX 77081 Phone: 713-533-1700 Fax: 713-533-1708 | |
Diana Atwal, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6630 De Moss Dr, Houston, TX 77074 Phone: 713-272-2600 Fax: 713-272-5589 |